Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Methicillin-resistant Staphylococcus aureus resistance to non-beta-lactam antimicrobials in the United States from 1996 to 2008.

Bordon J, Master RN, Clark RB, Duvvuri P, Karlowsky JA, Ayesu K, Klotchko A, Kapoor R, Ramirez J.

Diagn Microbiol Infect Dis. 2010 Aug;67(4):395-8. doi: 10.1016/j.diagmicrobio.2010.03.006.

PMID:
20638612
2.

Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration.

Harro JM, Peters BM, O'May GA, Archer N, Kerns P, Prabhakara R, Shirtliff ME.

FEMS Immunol Med Microbiol. 2010 Aug;59(3):306-23. doi: 10.1111/j.1574-695X.2010.00708.x. Epub 2010 May 29. Review.

3.

Methicillin resistance and vancomycin heteroresistance in Staphylococcus aureus in cystic fibrosis patients.

Cafiso V, Bertuccio T, Spina D, Campanile F, Bongiorno D, Santagati M, Sciacca A, Sciuto C, Stefani S.

Eur J Clin Microbiol Infect Dis. 2010 Oct;29(10):1277-85. doi: 10.1007/s10096-010-1000-5. Epub 2010 Jul 4.

PMID:
20602245
4.

Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.

Nannini E, Murray BE, Arias CA.

Curr Opin Pharmacol. 2010 Oct;10(5):516-21. doi: 10.1016/j.coph.2010.06.006. Epub 2010 Jul 1. Review.

PMID:
20598637
5.

Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States.

McDougal LK, Fosheim GE, Nicholson A, Bulens SN, Limbago BM, Shearer JE, Summers AO, Patel JB.

Antimicrob Agents Chemother. 2010 Sep;54(9):3804-11. doi: 10.1128/AAC.00351-10. Epub 2010 Jun 28.

6.

Decreased susceptibility to quinolones in methicillin-resistant Staphylococcus aureus isolated from ocular infections at a tertiary eye care centre.

Bagga B, Reddy AK, Garg P.

Br J Ophthalmol. 2010 Oct;94(10):1407-8. doi: 10.1136/bjo.2010.179747. Epub 2010 Jun 24. No abstract available.

PMID:
20576768
7.

Fusidic acid resistance rates and prevalence of resistance mechanisms among Staphylococcus spp. isolated in North America and Australia, 2007-2008.

Castanheira M, Watters AA, Bell JM, Turnidge JD, Jones RN.

Antimicrob Agents Chemother. 2010 Sep;54(9):3614-7. doi: 10.1128/AAC.01390-09. Epub 2010 Jun 21.

8.

Microbiological and molecular characterization of nosocomial and community Staphylococcus aureus isolates.

Scazzocchio F, Aquilanti L, Tabacchini C, Iebba V, Passariello C.

Epidemiol Infect. 2011 Apr;139(4):613-22. doi: 10.1017/S095026881000138X. Epub 2010 Jun 21.

PMID:
20561388
10.

Community and nosocomial transmission of Panton-Valentine leucocidin-positive community-associated meticillin-resistant Staphylococcus aureus: implications for healthcare.

Orendi JM, Coetzee N, Ellington MJ, Boakes E, Cookson BD, Hardy KJ, Hawkey PM, Kearns AM.

J Hosp Infect. 2010 Aug;75(4):258-64. doi: 10.1016/j.jhin.2010.03.023. Epub 2010 Jun 9.

PMID:
20542589
11.

Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit.

Sánchez García M, De la Torre MA, Morales G, Peláez B, Tolón MJ, Domingo S, Candel FJ, Andrade R, Arribi A, García N, Martínez Sagasti F, Fereres J, Picazo J.

JAMA. 2010 Jun 9;303(22):2260-4. doi: 10.1001/jama.2010.757.

PMID:
20530779
12.

The potential economic value of a Staphylococcus aureus vaccine for neonates.

Lee BY, Ufberg PJ, Bailey RR, Wiringa AE, Smith KJ, Nowalk AJ, Higgins C, Wateska AR, Muder RR.

Vaccine. 2010 Jun 23;28(29):4653-60. doi: 10.1016/j.vaccine.2010.04.069. Epub 2010 May 14.

13.

Staphylococcus aureus nasal colonization and subsequent infection in intensive care unit patients: does methicillin resistance matter?

Honda H, Krauss MJ, Coopersmith CM, Kollef MH, Richmond AM, Fraser VJ, Warren DK.

Infect Control Hosp Epidemiol. 2010 Jun;31(6):584-91. doi: 10.1086/652530.

14.

Evaluation of some Staphylococcus aureus iron-regulated proteins as vaccine targets.

Ster C, Beaudoin F, Diarra MS, Jacques M, Malouin F, Lacasse P.

Vet Immunol Immunopathol. 2010 Aug 15;136(3-4):311-8. doi: 10.1016/j.vetimm.2010.03.010. Epub 2010 Mar 21.

PMID:
20416953
15.

Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection.

Filice GA, Nyman JA, Lexau C, Lees CH, Bockstedt LA, Como-Sabetti K, Lesher LJ, Lynfield R.

Infect Control Hosp Epidemiol. 2010 Apr;31(4):365-73. doi: 10.1086/651094.

PMID:
20184420
16.

Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus.

Morales G, Picazo JJ, Baos E, Candel FJ, Arribi A, Peláez B, Andrade R, de la Torre MA, Fereres J, Sánchez-García M.

Clin Infect Dis. 2010 Mar 15;50(6):821-5. doi: 10.1086/650574.

PMID:
20144045
17.

Staphylococcus aureus vaccine for orthopedic patients: an economic model and analysis.

Lee BY, Wiringa AE, Bailey RR, Lewis GJ, Feura J, Muder RR.

Vaccine. 2010 Mar 11;28(12):2465-71. doi: 10.1016/j.vaccine.2009.12.075. Epub 2010 Jan 9.

18.

Preventing surgical-site infections in nasal carriers of Staphylococcus aureus.

Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, Roosendaal R, Troelstra A, Box AT, Voss A, van der Tweel I, van Belkum A, Verbrugh HA, Vos MC.

N Engl J Med. 2010 Jan 7;362(1):9-17. doi: 10.1056/NEJMoa0808939.

19.

Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions.

Moise PA, North D, Steenbergen JN, Sakoulas G.

Lancet Infect Dis. 2009 Oct;9(10):617-24. doi: 10.1016/S1473-3099(09)70200-2. Review.

PMID:
19778764
20.

Evaluating the potential public health impact of a Staphylococcus aureus vaccine through use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States.

Lucero CA, Hageman J, Zell ER, Bulens S, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Fridkin SK; Active Bacterial Core surveillance MRSA Investigators..

Vaccine. 2009 Aug 13;27(37):5061-8. doi: 10.1016/j.vaccine.2009.06.055. Epub 2009 Jul 2.

PMID:
19576943

Supplemental Content

Support Center